Home » Topics » Regulatory » NMPA

NMPA
RSS

China FDA accepts fruquintinib NDA for advanced colorectal cancer

June 12, 2017

Tagrisso approved in China for NSCLC

March 27, 2017

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Jan. 19, 2017

U.S. and China IND clearances for Ascentage's APG-1252

Dec. 28, 2016

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody

Oct. 21, 2016

BeiGene cleared to conduct clinical trials of BGB-A317 in China

Sep. 12, 2016

Chinese clinical trial authorization for TaiGen's furaprevir

Aug. 19, 2016

BioNano Genomics and Berry Genomics to codevelop next-generation mapping system

Aug. 18, 2016

Cervarix approved in China

July 18, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...